Whitehawk Therapeutics (WHWK) Operating Leases (2019 - 2024)
Whitehawk Therapeutics (WHWK) posted quarterly Operating Leases of $565000.0 for Q4 2024, down 32.17% year-over-year from $833000.0 in Q1 2024, and down 9.46% quarter-over-quarter from $624000.0 in Q3 2024.
Whitehawk Therapeutics (WHWK) Operating Leases (2019 - 2024) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Operating Leases for 6 consecutive years, with $565000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Operating Leases fell 32.17% year-over-year to $565000.0; the TTM figure through Dec 2024 stood at $565000.0 (down 32.17% YoY), while the FY2024 annual figure was $565000.0, down 32.17% from the prior year.
- Operating Leases slipped to $565000.0 in Q4 2024 per WHWK's latest filing, from $624000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $1.7 million in Q3 2022 and bottomed at $9955.0 in Q2 2020.
- Historically, Operating Leases has averaged $858882.9 across 5 years, with a median of $757500.0 in 2023.
- Annual changes were most pronounced in 2020 — Operating Leases sank 96.54% — and 2022, when it surged 250.42%.
- Whitehawk Therapeutics' Operating Leases stood at $9955.0 in 2020, then jumped by 4661.43% to $474000.0 in 2021, then soared by 250.42% to $1.7 million in 2022, then sank by 49.85% to $833000.0 in 2023, then sank by 32.17% to $565000.0 in 2024.
- Business Quant data shows WHWK's Operating Leases at $565000.0 in Q4 2024, $624000.0 in Q3 2024, and $682000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 565,000.00 |
| Sep 30, 2024 | 624,000.00 |
| Jun 30, 2024 | 682,000.00 |
| Mar 31, 2024 | 1.16 Mn |
| Dec 31, 2023 | 833,000.00 |
| Sep 30, 2023 | 946,000.00 |
| Jun 30, 2023 | 1.47 Mn |
| Mar 31, 2023 | 1.16 Mn |
| Dec 31, 2022 | 1.66 Mn |
| Sep 30, 2022 | 1.72 Mn |
| Jun 30, 2022 | 1.44 Mn |
| Mar 31, 2022 | 424,000.00 |
| Dec 31, 2021 | 474,000.00 |
| Sep 30, 2021 | 523,000.00 |
| Jun 30, 2020 | 9,955.00 |
| Mar 31, 2020 | 39,171.00 |
| Dec 31, 2019 | 67,438.00 |
| Sep 30, 2019 | 236,223.00 |
| Jun 30, 2019 | 288,055.00 |
| Mar 31, 2019 | 337,737.00 |